Opportunistic lung infection in patients with chronic obstructive pulmonary disease; a side effect of inhalation corticosteroids;OPPORTUNISTISCHE LONGINFECTIES BIJ PATIENTEN MET CHRONISCHE OBSTRUCTIEVE LONGZIEKTE; EEN BIJWERKING VAN INHALATIECORTICOSTEROIDEN?

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 2, 1996, Pages 94-98

  Smeenk, F W J M ^a   Klinkhamer, P J J M ^b   Breed, W ^a   Jansz, A R ^b   Jansveld, C A F ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FORMOTEROL; IPRATROPIUM BROMIDE; PREDNISOLONE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASPERGILLUS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFICACY; FEMALE; HUMAN; LUNG INFECTION; MALE; MYCOBACTERIUM; OPPORTUNISTIC INFECTION; PRESCRIPTION; THORAX RADIOGRAPHY; ASPERGILLOSIS; ATYPICAL MYCOBACTERIOSIS; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; ASPERGILLOSIS; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; OPPORTUNISTIC INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 0030070728     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148(4 Pt2):Sr-26.
2. British Thoracic Society. Guidelines for the management of asthma in adults. I. Chronic persistent asthma. BMJ 1990;301:651-3.
3. National Asthma Education Program. Management of asthma. J Allergy Clin Immunol 1995;88:477-93.
4. International Asthma Management Project. International consensus report on diagnosis and treatment of asthma. Part IV Establish medication plans for chronic management. Eur Respir J 1992;251:616-22.
5. Waart MAC van der, Dekker FW, Nijhoff S, Thiadens HA, Weel C van, Helder M, et al. NHG standaard CARA bij volwassenen. Behandeling Huisarts Wet 1992;35:437-43.
6. Yernault JC. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective. Eur Respir J 1992;5:1169-70.
7. Wedzicha JA. Inhaled corticosteroids in COPD: awaiting controlled trials. Thorax 1993;48:305-7.
8. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993;328:1017-22.
9. Auffarth B, Postma DS, Monchy JGR de, Mark ThW van der, Boorsma M, Koeter GH. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness. and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991;46:372-7.
10. Wever-Hess J, Kouwenberg JM, Wever AM. Trends in consulten en prescripties wegens CARA bij kinderen. Ned Tijdschr Geneeskd 1993;137:1246-51.
11. Molema J, Herwaarden CLA van. De medicamenteuze behandeling van CARA DIMS 1992;14:12-7.
12. Wagenaar JPM, Herwaarden CLA van. Behandeling van chronisch obstructief longlijden (COPD). DIMS 1993;16:12-5.
13. Toogood JH, Jennings B, Greenway RW, Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980;65:145-53
14. Milne LJ, Crompton GK. Beclomethasone dipropionate and oropharyngeal candidiasis. BMJ 1974;3:797-8.
15. Toogood JH, Jennings B, Baskerville J, Anderson J, Johansson SA. Dosing regimen of budesonide and occurence of oropharyngeal complications. Eur J Respir Dis 1984;65:35-44.
16. Sherman B, Weinberger M, Chen-Walden H, Wendt H. Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults. J Allergy Clin Immunol 1982;69:208-12.
17. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992;47 414-7.
18. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991;88:572-80
19. Heest JAC van, Bokma JA, Oudheusden LJ van, Stricker BHCh. Bijnierschorsremming toegeschreven aan het gebruik van budesonide. Ned Tijdschr Geneeskd 1994;138:2204-7.
20. Boulet LP, Giguere MC, Milot J, Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 1994;94:796-803.
21. Medical Research Council. Controlled trial of effects of cortisone acetate in chronic asthma. Report to the medical research council by the subcommittee on clinical trials in asthma. Lancet 1956:ii 798-806.
22. Briggs JD, Junor BJR, Long term complications and results in transplantation. In: Caneron S, Davison AM, Grunfeld JP, Kerr D, Ritz E. editors. Oxford textbook of nefrology Oxford: Oxford University Press, 1992:1570-94.
23. Frank MM, Lawley TJ. Immune complex diseases. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL. editors. Harrison's principles of internal medicine. New York: McGraw-Hill. 1994:1638-42.
24. Haynes RC. Adrenocorticotropic hormone. In: Goodman Gillman A, Rull TW, Nies AS, Taylor P. editors. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990:1431-63.
25. Elsasser W, Eickstedt KW von. Corticotrophins and corticosteroids. In: Dukes MNG, editor. Meyler's side effects of drugs. Amsterdam: Elsevier Scientific Publishers, 1992:977-94.
26. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
27. Aalbers R, Smith M, Timens W. Immunohistology in bronchial asthma. Respir Med 1993;87 Suppl B:13-21.
28. Locksley RM, Wilson CB. Cell mediated immunity and its role in host defense. In: Mandell GL, Bennet JE, Dolin R. editors. Basic principles in the diagnosis and management of infectious diseases. New York: Churchill Livingstone, 1995:102-48.
29. 29 Thorsson L, Edsbacker S, Conradson TB. Lung deposition of budesonide from turbuhaler is twice that from a pressurized metereddose inhaler (P-MDI). Eur Respir J 1994;7:1839-44.
30. Meichor R, Biddiscombe MF, Mak VH, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993;48:506-11.
31. Jarrousse B, Guillevin L, Bindi P, Hachulla E, Leclerc P, Gilson B, et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 1993;11:615-21.
32. 32 Nagata N, Nikaido Y, Kido M, Ishibashi T, Sueishi K. Terminal pulmonary infections in patients with lung cancer. Chest 1993;103:1739-42.
33. Abernathy-Carver KJ, Fan LL, Boguniewicz M, Larsen GL, Leung DY. Legionella and Pneumocystis pneumonias in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol 1994;18:135-8.
34. Wiest PM, Flanigan T, Salata RA, Shlaes DM, Katzman M, Lederman MM. Serious infectious complications of corticosteroid therapy for COPD. Chest 1989;95:1180-4.
35. Walsh TJ, Lee JW. Prevention of invasive fungal infections in patients with neoplastic disease. Clin Infect Dis 1993;17 Suppl 2: S468-80
36. Soub H al-, Iskander S, Uwaydah AK. Cerebral aspergillosis. Br J Clin Pract 1993;47:334-5.
37. Shaikh WA. Pulmonary tuberculosis in patients treated with inhaled beclomethasone. Allergy 1992;47(4 Pt 1):327-30.